Results 31 to 40 of about 633,971 (314)
BMC Public Health, 2019 Background Streptococcus pneumoniae causes substantial morbidity and mortality among children. The introduction of pneumococcal conjugate vaccines (PCV) has the potential to dramatically reduce disease burden.
S. F. La Vincente +18 more
doaj +1 more source
Accurate Measures of Vaccination and Concerns of Vaccine Holdouts from Web Search Logs [PDF]
, 2023 To design effective vaccine policies, policymakers need detailed data about who has been vaccinated, who is holding out, and why. However, existing data in the US are insufficient: reported vaccination rates are often delayed or missing, and surveys of vaccine hesitancy are limited by high-level questions and self-report biases. Here, we show how large-
arxiv +1 more source
Journal of Viral Hepatitis, Volume 30, Issue 1, Page 4-18, January 2023., 2023 Abstract Hepatitis B, caused by the hepatitis B virus (HBV), is a global public health issue that affects 290 million people worldwide. Most people with hepatitis B are in low‐ and middle‐income countries (LMIC), where health systems and resources are often constrained.
Caroline Lee +2 more
wiley +1 more source
The role of Pneumococcal vaccine [PDF]
Pulmonary Pharmacology & Therapeutics, 2008 Streptococcus pneumoniae pathologies represent a health problem of primary importance worldwide in terms of morbidity, mortality, and costs. S. pneumoniae is the main aetiological agent of bacterial pneumonia, and is frequently involved in bacterial meningitis, chronic obstructive pulmonary disease (COPD) exacerbations and upper airway pathologies. The
BRAIDO, FULVIO +4 more
openaire +6 more sources
Annali di igiene : medicina preventiva e di comunita, 2001 Gli autori descrivono le caratteristiche del vaccino anti-pneumococcico polisaccaridi, ponendo una particolare attenzione alla sua efficacia e tollerabilità nella popolazione anziana.
D'ALESSANDRO, Daniela, Y. Kodra
openaire +6 more sources
30-Minute Highly Multiplexed VaxArray Immunoassay for Pneumococcal Vaccine Antigen Characterization
Vaccines, 2022 Pneumonia accounts for over 20% of deaths worldwide in children aged 1 to 5 years, disproportionately affecting lower- and middle-income countries.
Tianjing Hu +11 more
doaj +1 more source
A Trial of a 7-Valent Pneumococcal Conjugate Vaccine in HIV-Infected Adults. [PDF]
, 2010 BACKGROUND: Streptococcus pneumoniae is a leading and serious coinfection in adults with human immunodeficiency virus (HIV) infection, particularly in Africa.
French, N +9 more
core +2 more sources
Indirect effect of 7-valent and 13-valent pneumococcal conjugated vaccines on pneumococcal pneumonia hospitalizations in elderly [PDF]
, 2018 Background: Pneumonia is one of the leading causes of mortality and has a high burden in morbidity. In Portugal, 7-valent pneumococcal conjugated vaccine (PCV) was used since 2001 and PCV10/13 since 2009, being the last introduced into the National ...
Froes, Filipe +6 more
core +2 more sources
Efficacy and Effectiveness of the PCV-10 and PCV-13 Vaccines Against Invasive Pneumococcal Disease
Pediatrics, 2020 Two PCVs are licensed for prevention of pneumococcal disease. Uncertainty about the effectiveness against AOM and serotype 19A invasive disease in children ≤5 years remains.
Melissa Berman-Rosa +3 more
semanticscholar +1 more source
Challenges in estimating the impact of pneumococcal conjugate vaccines through surveillance [PDF]
, 2012 SCOPUS: re.jinfo:eu-repo/semantics ...
Hanquet, Germaine, Vergison, Anne
core +1 more source